Free Trial
CVE:LTY

Liberty Biopharma (LTY) Stock Price, News & Analysis

C$2.00
+2.00 (+∞)
(As of 10/10/2018)
Today's Range
C$2.00
C$2.00
50-Day Range
C$2.00
C$2.00
52-Week Range
C$0.06
C$2.74
Volume
700 shs
Average Volume
23,286 shs
Market Capitalization
C$21.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
LTY stock logo

About Liberty Biopharma Stock (CVE:LTY)

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.

LTY Stock Price History

LTY Stock News Headlines

This is the type of environment we pray for…
There is a situation in the market right now that requires your immediate attention. It involves a company that has $9 billion in cash, only $500,000 in debt, and a market cap of around $8 billion. This may not mean much to you right now.
Redhill Biopharma Ltd ADR
This is the type of environment we pray for…
There is a situation in the market right now that requires your immediate attention. It involves a company that has $9 billion in cash, only $500,000 in debt, and a market cap of around $8 billion. This may not mean much to you right now.
Liberty 99, St. Andrews 26
Liberty Home Guard review
LDDFF Liberty Defense Holdings, Ltd.
See More Headlines
Receive LTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.00 per share
Book Value
C$0.79 per share

Miscellaneous

Free Float
N/A
Market Cap
C$21.54 million
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Norman Tsui (Age 45)
    Pres, CEO & Director
  • Mr. Shui Yan Tam (Age 44)
    Chief Financial Officer
  • Dr. Michael T. McNamara
    Medical Advisor & Director
  • Dr. Richard Huang Ph.D. (Age 42)
    Chief Technology Officer
  • Dr. Richard Cook M.D.
    Msc., FRCSC, Chief Medical Officer

LTY Stock Analysis - Frequently Asked Questions

How have LTY shares performed this year?

Liberty Biopharma's stock was trading at C$2.00 at the beginning of the year. Since then, LTY stock has increased by 0.0% and is now trading at C$2.00.
View the best growth stocks for 2024 here
.

How do I buy shares of Liberty Biopharma?

Shares of LTY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Liberty Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Liberty Biopharma investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Arbor Realty Trust (ABR) and Advanced Emissions Solutions (ADES).

This page (CVE:LTY) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners